Safety and Preliminary Efficacy of SBRT in Patients With Metastatic RCC Treated With Targeted or IO Therapy

NCT02864615 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma

Interventions

RADIATION: SBRT

Sponsor

Kidney Cancer Research Bureau